Page last updated: 2024-11-01

nimodipine and Ear Neoplasms

nimodipine has been researched along with Ear Neoplasms in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Ear Neoplasms: Tumors or cancer of any part of the hearing and equilibrium system of the body (the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scheller, C1
Vogel, AS1
Simmermacher, S1
Rachinger, JC1
Prell, J1
Strauss, C1
Reinsch, M1
Kunter, U1
Wienke, A1
Neumann, J1
Scheller, K1

Other Studies

1 other study available for nimodipine and Ear Neoplasms

ArticleYear
Prophylactic intravenous nimodipine treatment in skull base surgery: pharmacokinetic aspects.
    Journal of neurological surgery. Part A, Central European neurosurgery, 2012, Volume: 73, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Blood Pressure; Calcium Channel Blockers; Chrom

2012